But then again MSB messed up the aGVHD trial which the FDA were unhappy about...
so their record is hardly unblemished.
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain, page-161
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.013(1.07%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.19 | $1.17 | $1.349M | 1.149M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 113399 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 52219 | 12 |
View Market Depth
| Last trade - 11.12am 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |